Blankinship & Foster »

Summit Therapeutics shares owned by Blankinship & Foster

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Blankinship & Foster from 13F filings

Historical chart of Blankinship & Foster investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Blankinship & Foster consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Blankinship & Foster

Quarter filed Position value Share count Share price at filing
2023-12-31 $33k 13k 2.61
2023-09-30 $24k 13k 1.87
2023-06-30 $32k 13k 2.51

More positions owned by Blankinship & Foster

Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Vanguard Index Fds Mid Cap Etf (VO)
Dbx Etf Tr Xtrack Msci Eafe (DBEF)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Hdg Msci Eafe (HEFA)
Vanguard World Fds Consum Stp Etf (VDC)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Msci Eafe Etf (EFA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Abbvie (ABBV)

View all positions for Blankinship & Foster

Top funds holding Summit Therapeutics

BlackRock
FMR
Vanguard Group
Geode Capital Management
Northern Trust
Charles Schwab Investment Management
Morgan Stanley
Goldman Sachs Group
Rafferty Asset Management
Steward Partners Investment Advisory
Bank Of Montreal
Citigroup
ALPS Advisors
UBS Group
Barclays

View all funds holding Summit Therapeutics